Severe inflammation in the background liver cirrhosis correlates with the development of poorly differentiated HCC in HCV-associated liver cirrhosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Internal medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.51.7744PMID 22989817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI.

  2011cited by this paper
• Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.

  2011cited by this paper
• Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.

  2010cited by this paper
• C型慢性肝疾患（慢性肝炎・肝硬変症）難治例に対して十全大補湯は第3の肝庇護剤になりえるか

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• WHO Classification of Tumours of the Digestive System

  2010cited by this paper
• High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis

  2009cited by this paper
• SPACE OCCUPYING LESIONS IN THE LIVER

  2009cited by this paper
• A lymphotoxin-driven pathway to hepatocellular carcinoma.

  2009cited by this paper
• Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.

  2008cited by this paper
• Edmondson-Steiner Grading Increases the Predictive Efficiency of TNM Staging for Long-term Survival of Patients with Hepatocellular Carcinoma After Curative Resection

  2008cited by this paper
• Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.

  2007cited by this paper
• Efficacy of low dose long‐term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha‐fetoprotein: A pilot study

  2007cited by this paper
• A cytokine-mediated link between innate immunity, inflammation, and cancer.

  2007cited by this paper
• Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon

  2006cited by this paper
• Paradoxical roles of the immune system during cancer development

  2006cited by this paper
• Interferon Therapy for 2 Years or Longer Reduces the Incidence of Hepatocarcinogenesis in Patients with Chronic Hepatitis C Viral Infection

  2004cited by this paper
• Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus‐associated cirrhosis

  1999cited by this paper
• A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia.

  1999cited by this paper
• Factors affecting postoperative prognosis in the solitary-nodule type of hepatocellular carcinoma: experience of 132 cases in our institute.

  1998cited by this paper
• The long term efficacy of glycyrrhizin in chronic hepatitis C patients

  1997cited by this paper
• Pathology of early hepatocellular carcinoma: progression from early to advanced.

  1996cited by this paper
• Prospective study of chemoprevention of hepatocellular carcinoma with sho‐saiko‐to (TJ‐9)

  1995cited by this paper
• Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial.

  1993cited by this paper
• DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC

  1993cited by this paper
• Progression of Weakly Malignant Clone Cells Derived from Rat Mammary Carcinoma by Host Cells Reactive to Plastic Plates

  1992cited by this paper
• The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound‐guided fine‐needle biopsy with those of autopsy

  1992cited by this paper
• Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.

  1991cited by this paper
• Pathomorphologic characteristics of early hepatocellular carcinoma

  1991cited by this paper
• Biopsy diagnosis of well‐differentiated hepatocellular carcinoma based on new morphologic criteria

  1989cited by this paper
• A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis

  1989cited by this paper
• Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC

  1987cited by this paper
• Tumorigenicity of sarcoma cells is enhanced by the local environment of implanted foreign body

  1982cited by this paper
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

  1981influential reference
• Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies

  1954cited by this paper
• A Large-scale, Multicentre, Double-blind Trial of Ursodeoxycholic Acid in Patients with Chronic Hepatitis C

  year unknowncited by this paper

• Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study

  2024cites this paper
• Serum Endotoxin Level in Cirrhotic Patients with Hepatic Encephalopathy

  2021cites this paper
• Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis

  2016cites this paper
• Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection

  2015cites this paper
• Nódulo hepático no paciente hepatopata. Diagnóstico e conduta

  2015cites this paper